436 related articles for article (PubMed ID: 32726826)
1. The Evolution of Hemophilia Care: Clinical and Laboratory Advances, Opportunities, and Challenges.
Trinchero A; Sholzberg M; Matino D
Hamostaseologie; 2020 Aug; 40(3):311-321. PubMed ID: 32726826
[TBL] [Abstract][Full Text] [Related]
2. Emerging genetic and pharmacologic therapies for controlling hemostasis: beyond recombinant clotting factors.
Monahan PE
Hematology Am Soc Hematol Educ Program; 2015; 2015():33-40. PubMed ID: 26637698
[TBL] [Abstract][Full Text] [Related]
3. New therapies for hemophilia.
Weyand AC; Pipe SW
Blood; 2019 Jan; 133(5):389-398. PubMed ID: 30559264
[TBL] [Abstract][Full Text] [Related]
4. New therapies using nonfactor products for patients with hemophilia and inhibitors.
Nogami K; Shima M
Blood; 2019 Jan; 133(5):399-406. PubMed ID: 30559263
[TBL] [Abstract][Full Text] [Related]
5. Thromboembolic Risks of Non-Factor Replacement Therapies in Hemophilia.
Tiede A
Hamostaseologie; 2017; 37(4):307-310. PubMed ID: 29582931
[No Abstract] [Full Text] [Related]
6. Setting the stage for individualized therapy in hemophilia: What role can pharmacokinetics play?
Hazendonk HCAM; van Moort I; Mathôt RAA; Fijnvandraat K; Leebeek FWG; Collins PW; Cnossen MH;
Blood Rev; 2018 Jul; 32(4):265-271. PubMed ID: 29426727
[TBL] [Abstract][Full Text] [Related]
7. The changing treatment landscape in haemophilia: from standard half-life clotting factor concentrates to gene editing.
Mancuso ME; Mahlangu JN; Pipe SW
Lancet; 2021 Feb; 397(10274):630-640. PubMed ID: 33460559
[TBL] [Abstract][Full Text] [Related]
8. How do we optimally utilize factor concentrates in persons with hemophilia?
Lim MY
Hematology Am Soc Hematol Educ Program; 2021 Dec; 2021(1):206-214. PubMed ID: 34889393
[TBL] [Abstract][Full Text] [Related]
9. Safety of recombinant coagulation factors in treating hemophilia.
Morfini M; Rapisarda CAP
Expert Opin Drug Saf; 2019 Feb; 18(2):75-85. PubMed ID: 30681006
[TBL] [Abstract][Full Text] [Related]
10. A Molecular Revolution in the Treatment of Hemophilia.
Butterfield JSS; Hege KM; Herzog RW; Kaczmarek R
Mol Ther; 2020 Apr; 28(4):997-1015. PubMed ID: 31843450
[TBL] [Abstract][Full Text] [Related]
11. Factor VIII-Mimetic Function of Humanized Bispecific Antibody in Hemophilia A.
Shima M; Hanabusa H; Taki M; Matsushita T; Sato T; Fukutake K; Fukazawa N; Yoneyama K; Yoshida H; Nogami K
N Engl J Med; 2016 May; 374(21):2044-53. PubMed ID: 27223146
[TBL] [Abstract][Full Text] [Related]
12. Recent advances in developing specific therapies for haemophilia.
Ling G; Nathwani AC; Tuddenham EGD
Br J Haematol; 2018 Apr; 181(2):161-172. PubMed ID: 29359795
[TBL] [Abstract][Full Text] [Related]
13. Confronting COVID-19: Issues in Hemophilia and Congenital Bleeding Disorders.
Coppola A; Tagliaferri A; Rivolta GF; Quintavalle G; Franchini M
Semin Thromb Hemost; 2020 Oct; 46(7):819-822. PubMed ID: 32512586
[No Abstract] [Full Text] [Related]
14. Hemophilia in a Changing Treatment Landscape.
Pelland-Marcotte MC; Carcao MD
Hematol Oncol Clin North Am; 2019 Jun; 33(3):409-423. PubMed ID: 31030810
[TBL] [Abstract][Full Text] [Related]
15. Prophylaxis for hemophilia A without inhibitors: treatment options and considerations.
Valentino LA; Khair K
Expert Rev Hematol; 2020 Jul; 13(7):731-743. PubMed ID: 32573295
[TBL] [Abstract][Full Text] [Related]
16. Advances and challenges for hemophilia gene therapy.
Batty P; Lillicrap D
Hum Mol Genet; 2019 Oct; 28(R1):R95-R101. PubMed ID: 31332444
[TBL] [Abstract][Full Text] [Related]
17. Prophylactic treatment in hemophilic patients with inhibitors.
Haya S
Blood Coagul Fibrinolysis; 2019 Sep; 30(1S Suppl 1):S14-S18. PubMed ID: 31517711
[TBL] [Abstract][Full Text] [Related]
18. The safety of pharmacologic options for the treatment of persons with hemophilia.
Franchini M; Mannucci PM
Expert Opin Drug Saf; 2016 Oct; 15(10):1391-400. PubMed ID: 27367551
[TBL] [Abstract][Full Text] [Related]
19. The past and future of haemophilia: diagnosis, treatments, and its complications.
Peyvandi F; Garagiola I; Young G
Lancet; 2016 Jul; 388(10040):187-97. PubMed ID: 26897598
[TBL] [Abstract][Full Text] [Related]
20. Hemophilia Gene Therapy: Ready for Prime Time?
VandenDriessche T; Chuah MK
Hum Gene Ther; 2017 Nov; 28(11):1013-1023. PubMed ID: 28793786
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
